Search
for
Sort by
Research 481–510 of 1000+
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
- Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study
- ALOPECIA AREATA: ASPECTOS FISIOLÓGICOS E AVANÇOS TERAPÊUTICOS – UMA REVISÃO DE LITERATURA
- Recalcitrant lichen planopilaris treated with upadacitinib: a case series
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Ritlecitinib: First Approval
- Learning from nudity: lessons from the nude phenotype
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Review of Baricitinib in the Treatment of Alopecia Areata.
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Drug-induced hair pigmentation: Clinical perspectives and updates
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- CPK1 activates CNGCs through phosphorylation for Ca2+ signaling to promote root hair growth in Arabidopsis